Ledger.Open graph →

SEC Form D · filed May 27, 2022

Elicio Therapeutics, Inc

Offering

$50.0M

Sold

$975K

Exemption

Rule 506(b)

Industry

Biotechnology

Location

BOSTON, MA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (26)

Robert Connelly · Boston, MAExec · Director Daphne Karydas · Boston, MADirector Daniel Geffken · Boston, MAExec · Director Christopher Haqq · Boston, MAExec Carol Ashe · Boston, MADirector Robert Ruffolo · Boston, MADirector Annette Matthies · Boston, MAExec Julian Adams · Boston, MADirector Christophe Seywert · Grand Duchy of Luxembourg, LuxembourgDirector Jared Champlin · Dallas, TXExec · Director Thomas Gardner · Wichita, KSExec Mark Disiena · Wichita, KSExec Daniel Hilson · ANN ARBOR, MIDirector Kelly Anderson · Wichita, KSExec · Director Grant Begley · Wichita, KSDirector Anthony Brasher · ANN ARBOR, MIDirector Ofer Gonen · Boston, MADirector Julian R. Marcu · CHELSEA, MADirector Ellen R. Reilly · CHELSEA, MAExec Thomas Hulick · Pasadena, CADirector John Dunkelberger · Eden Prairie, MNExec · Director Thomas Mallon · INCLINE VILLAGE, NVExec Antonio Salgado · Long Beach, NYExec · Director Marc Jordan · Encino, CADirector H. M. Chambers · Leeds, ALDirector Ofer Gonen · Boston, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗